Business Continuity During and After the Pandemic: What Lessons Can Be Taken to the Future? - SPANISH

Speaker(s):

• Robin Levis

Session Chair(s):

• Daniela Manzoli Bravo, Bayer S.A. – Brazil
• Kavita Aiyer, Seagen Inc.
• Maria Cristina Mota Pina, AbbVie, Inc.
• Maria Cecilia Tami, Genentech, a Member of the Roche Group

Session Speaker(s):

• Ihatanderson Alves da Silva, ANVISA-National Health Surveillance Agency
• Stephan Rönninger, Amgen (Europe) GMBH, Switzerland
• Rebecca Lumsden, Pfizer Limited, United Kingdom - representing FIFARMA

Panel Member(s):

• Patriciá Aprea, ANMAT- National Administration of Medicines, Food and Medical Technology
• Iris Lorena Arreola Dominguez, COFEPRIS-Federal Commission for the Protections from Sanitary Risks
• Miguel Angel Sare Cruz, DIGEMID-General Directorate of Medicines, Supplies and Drugs